Yu-Ting (Helen) Hsu, Ph.D. is a Senior Scientist, Process and Analytical Development at MilliporeSigma. She first joined MilliporSigma in 2017 and later transferred to the Process and Analytical Development team in St. Louis in September 2020. She has been leading the binding assay development focusing on Surface Plasmon Resonance (SPR)-based assays to characterize biologics including monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). She received a Ph.D. in chemistry focused on Biosensor development from Massey University (New Zealand) and completed her postdoctoral research at Durham University (United Kingdom).
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.